1. Home
  2. QH vs VTGN Comparison

QH vs VTGN Comparison

Compare QH & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

N/A

Current Price

$2.79

Market Cap

8.0M

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QH
VTGN
Founded
2012
1998
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
9.5M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
QH
VTGN
Price
$2.79
$0.17
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
2.5K
★ 751.6K
Earning Date
11-17-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ N/A
N/A
Revenue This Year
N/A
$33.96
Revenue Next Year
N/A
N/A
P/E Ratio
$2.86
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.07
$0.17
52 Week High
$12.81
$5.14

Technical Indicators

Market Signals
Indicator
QH
VTGN
Relative Strength Index (RSI) 31.03 34.95
Support Level $0.08 N/A
Resistance Level $5.32 $0.32
Average True Range (ATR) 0.14 0.01
MACD -0.02 0.00
Stochastic Oscillator 5.75 5.96

Price Performance

Historical Comparison
QH
VTGN

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: